Search

Nanda Bondade

Examiner (ID: 1930)

Most Active Art Unit
2912
Art Unit(s)
2902, 2900, 2912
Total Applications
5029
Issued Applications
4983
Pending Applications
0
Abandoned Applications
46

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17334576 [patent_doc_number] => 20220000907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-06 [patent_title] => MOUTHWASH/GARGLE, NASAL/ORAL/NASAL SPRAY COVID AND BACTERIOCIDE ARRANGEMENT [patent_app_type] => utility [patent_app_number] => 17/189455 [patent_app_country] => US [patent_app_date] => 2021-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7157 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17189455 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/189455
MOUTHWASH/GARGLE, NASAL/ORAL/NASAL SPRAY COVID AND BACTERIOCIDE ARRANGEMENT Mar 1, 2021 Abandoned
Array ( [id] => 16899109 [patent_doc_number] => 20210178025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES [patent_app_type] => utility [patent_app_number] => 17/188634 [patent_app_country] => US [patent_app_date] => 2021-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6145 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188634 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/188634
ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES Feb 28, 2021 Abandoned
Array ( [id] => 16898838 [patent_doc_number] => 20210177754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => NANOEMULSION FOR ORAL USE [patent_app_type] => utility [patent_app_number] => 17/185087 [patent_app_country] => US [patent_app_date] => 2021-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16153 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17185087 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/185087
NANOEMULSION FOR ORAL USE Feb 24, 2021 Pending
Array ( [id] => 19134593 [patent_doc_number] => 11969502 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-30 [patent_title] => Oral products [patent_app_type] => utility [patent_app_number] => 17/183580 [patent_app_country] => US [patent_app_date] => 2021-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 23164 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17183580 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/183580
Oral products Feb 23, 2021 Issued
Array ( [id] => 17050517 [patent_doc_number] => 20210259951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => Transmucosal Drug Delivery System [patent_app_type] => utility [patent_app_number] => 17/177430 [patent_app_country] => US [patent_app_date] => 2021-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7809 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17177430 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/177430
Transmucosal Drug Delivery System Feb 16, 2021 Pending
Array ( [id] => 16990058 [patent_doc_number] => 20210228478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => TRANEXAMIC ACID SPRAY FOR KNEE ARTHROPLASTY [patent_app_type] => utility [patent_app_number] => 17/169403 [patent_app_country] => US [patent_app_date] => 2021-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4447 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169403 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/169403
TRANEXAMIC ACID SPRAY FOR KNEE ARTHROPLASTY Feb 5, 2021 Pending
Array ( [id] => 16990058 [patent_doc_number] => 20210228478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => TRANEXAMIC ACID SPRAY FOR KNEE ARTHROPLASTY [patent_app_type] => utility [patent_app_number] => 17/169403 [patent_app_country] => US [patent_app_date] => 2021-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4447 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169403 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/169403
TRANEXAMIC ACID SPRAY FOR KNEE ARTHROPLASTY Feb 5, 2021 Pending
Array ( [id] => 17005271 [patent_doc_number] => 20210236432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-05 [patent_title] => COMPOSITIONS COMPRISING ROFLUMILAST FOR TREATING HIDRADENITIS SUPPURATIVA AND PRURIGO NODULARIS [patent_app_type] => utility [patent_app_number] => 17/166336 [patent_app_country] => US [patent_app_date] => 2021-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6365 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17166336 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/166336
COMPOSITIONS COMPRISING ROFLUMILAST FOR TREATING HIDRADENITIS SUPPURATIVA AND PRURIGO NODULARIS Feb 2, 2021 Abandoned
Array ( [id] => 16853362 [patent_doc_number] => 20210154107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-27 [patent_title] => PARTICLES CONTAINING COLORING AGENTS AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/164308 [patent_app_country] => US [patent_app_date] => 2021-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23610 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -50 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17164308 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/164308
PARTICLES CONTAINING COLORING AGENTS AND METHODS OF USING THE SAME Jan 31, 2021 Pending
Array ( [id] => 16990633 [patent_doc_number] => 20210229053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => AMINO ACID SURFACTANTS [patent_app_type] => utility [patent_app_number] => 17/154919 [patent_app_country] => US [patent_app_date] => 2021-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4227 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17154919 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/154919
AMINO ACID SURFACTANTS Jan 20, 2021 Pending
Array ( [id] => 17290839 [patent_doc_number] => 20210386678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-16 [patent_title] => BIOPOLYMER-ENCAPSULATED GLYCOSYL TRANSFERASE INHIBITOR COMPOSITIONS AND METHODS FOR TREATING DIABETES AND CARDIAC INDICATIONS [patent_app_type] => utility [patent_app_number] => 17/152708 [patent_app_country] => US [patent_app_date] => 2021-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15328 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17152708 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/152708
BIOPOLYMER-ENCAPSULATED GLYCOSYL TRANSFERASE INHIBITOR COMPOSITIONS AND METHODS FOR TREATING DIABETES AND CARDIAC INDICATIONS Jan 18, 2021 Abandoned
Array ( [id] => 18232076 [patent_doc_number] => 11596618 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-03-07 [patent_title] => Oral cannabinoid delivery formulations with mouthfeel experience enhancers [patent_app_type] => utility [patent_app_number] => 17/150418 [patent_app_country] => US [patent_app_date] => 2021-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15675 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17150418 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/150418
Oral cannabinoid delivery formulations with mouthfeel experience enhancers Jan 14, 2021 Issued
Array ( [id] => 16961596 [patent_doc_number] => 20210213095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-15 [patent_title] => COMPOSITIONS AND METHODS FOR ACTIVATING CELLULAR SIGNALING PATHWAYS [patent_app_type] => utility [patent_app_number] => 17/148448 [patent_app_country] => US [patent_app_date] => 2021-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23764 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17148448 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/148448
COMPOSITIONS AND METHODS FOR ACTIVATING CELLULAR SIGNALING PATHWAYS Jan 12, 2021 Abandoned
Array ( [id] => 17748275 [patent_doc_number] => 20220226478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => FILM-FORMING COMPOSITION CONTAINING GELLAN GUM AND STARCH, AND APPLICATION IN SOFT CAPSULE [patent_app_type] => utility [patent_app_number] => 17/614644 [patent_app_country] => US [patent_app_date] => 2020-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7079 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614644 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/614644
FILM-FORMING COMPOSITION CONTAINING GELLAN GUM AND STARCH, AND APPLICATION IN SOFT CAPSULE Dec 27, 2020 Pending
Array ( [id] => 16930883 [patent_doc_number] => 20210196772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => CONFECTIONS FOR SKIN PROTECTION: COMPOSITIONS, METHODS FOR MAKING, AND APPLICATIONS THEREOF [patent_app_type] => utility [patent_app_number] => 17/133460 [patent_app_country] => US [patent_app_date] => 2020-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7107 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17133460 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/133460
CONFECTIONS FOR SKIN PROTECTION: COMPOSITIONS, METHODS FOR MAKING, AND APPLICATIONS THEREOF Dec 22, 2020 Abandoned
Array ( [id] => 16976124 [patent_doc_number] => 20210220361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR [patent_app_type] => utility [patent_app_number] => 17/133094 [patent_app_country] => US [patent_app_date] => 2020-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9489 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17133094 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/133094
SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR Dec 22, 2020 Abandoned
Array ( [id] => 17576974 [patent_doc_number] => 20220133829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-05 [patent_title] => ANTIVIRAL COMPOSITIONS AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 17/127589 [patent_app_country] => US [patent_app_date] => 2020-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6665 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17127589 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/127589
Antiviral compositions and methods of using same Dec 17, 2020 Issued
Array ( [id] => 16914073 [patent_doc_number] => 20210187165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => Collagen Tissue Modification [patent_app_type] => utility [patent_app_number] => 17/122392 [patent_app_country] => US [patent_app_date] => 2020-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8914 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17122392 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/122392
Collagen Tissue Modification Dec 14, 2020 Pending
Array ( [id] => 17655190 [patent_doc_number] => 20220175655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => CALLUS LYSATE COMPRISING HIGH CONTENT OF CALLUS METABOLITE AND PREPARATION METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 17/112591 [patent_app_country] => US [patent_app_date] => 2020-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12071 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112591 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/112591
Callus lysate comprising high content of callus metabolite and preparation method thereof Dec 3, 2020 Issued
Array ( [id] => 16898977 [patent_doc_number] => 20210177893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => Composition and method for treating and healing Medication-Related Osteonecrosis of the Jaw (MRONJ) [patent_app_type] => utility [patent_app_number] => 17/110249 [patent_app_country] => US [patent_app_date] => 2020-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4163 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17110249 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/110249
Composition and method for treating and healing Medication-Related Osteonecrosis of the Jaw (MRONJ) Dec 1, 2020 Abandoned
Menu